BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021

NEXT STORY
SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX
PREV STORY
Arch Biopartners Completes Enrollment in Phase II Trial of Metablok (LSALT Peptide) in Hospitalized Patients with COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Leading-edge Scientists in Innate Immunity Join Qu Biologics’ Scientific Advisory Board

VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical ...

author_avatar
NASDAQ Market News

Dr. Lowell Ackerman Joins LifeLearn

GUELPH, Ontario, Sept. 22, 2015 (GLOBE NEWSWIRE) -- LifeLearn Inc., a company devoted to ...

author_avatar
NASDAQ Market News

Auris Medical Completes Enrollment of Phase 3 TACTT3 Trial with Keyzilen in Acute and Post-Acute Inner Ear Tinnitus

Top-line results from TACTT3 trial expected in the fourth quarter Data to complement results ...

author_avatar
NASDAQ Market News